Abstract This work outlines the creation of a novel Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method for the quantitative detection of Empagliflozin and Linagliptin in bulk and tablet forms. The approach is quick, accurate, sensitive, and sensitive. The approach may be utilised for regular monitoring of Empagliflozin and Linagliptin in industry in the assay of bulk medication and dosage form due to the low percent relative standard deviation (% RSD) results in the precision research.
Keywords Empagliflozin, Linagliptin, RP-HPLC, Dosage form, Method Development.